SLB
46
-3
LEG
29
5
ROK
52
-2
FFIV
73
9
DAL
83
4
GLW
63
6
AMAT
48
4
BXP
60
-2
SE
54
-4
CINF
35
-3
IP
57
-7
PLD
50
-5
LEN
48
-5
CNP
47
-2
PYPL
45
-7
KLAC
45
3
RF
58
-3
AES
41
-2
WY
51
-5
V
52
-2
SLB
46
-3
LEG
29
5
ROK
52
-2
FFIV
73
9
DAL
83
4
GLW
63
6
AMAT
48
4
BXP
60
-2
SE
54
-4
CINF
35
-3
IP
57
-7
PLD
50
-5
LEN
48
-5
CNP
47
-2
PYPL
45
-7
KLAC
45
3
RF
58
-3
AES
41
-2
WY
51
-5
V
52
-2
Financhill
Back

Mirum Pharmaceuticals 10K Form

Buy
64

MIRM
Mirum Pharmaceuticals

Last Price:
39.86
Seasonality Move:
33.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MIRM News And Ratings

See the #1 stock for the next 7 days that we like better than MIRM

MIRM Financial Statistics

Sales & Book Value

Annual Sales: $186.37M
Cash Flow: $-14.58M
Price / Cash Flow: 0
Annual Sales: $4.81
Price / Book: 8.13

Profitability

EPS (TTM): -2.33950
Net Income (TTM): $-109.16M
Gross Margin: $139.34M
Return on Equity: -51.5%
Return on Assets: -17.88%

Mirum Pharmaceuticals Earnings Forecast

Key Mirum Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 4 years for MIRM is 74.76%.
  • The Selling, General & Administrative Expenses for MIRM have been equal to 78.27% of Gross Profit Margin.
  • The Research & Development expenses have been 55.06% of Revenue.
  • The Interest Expense is -9.24% of Operating Income.
  • The Net Earning history of MIRM is -87.68% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 3 years.

Mirum Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MIRM
CUSIP: 604749
Website: mirumpharma.com

Debt

Debt-to-Equity Ratio: 1.34
Current Ratio: 3.28
Quick Ratio: 3.02

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MIRM Technical Analysis vs Fundamental Analysis

Buy
64
Mirum Pharmaceuticals (MIRM) is a Buy

Is Mirum Pharmaceuticals a Buy or a Sell?